BioNano Genomics, Inc. (BNGO) Tops Q4 EPS by 10c

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 EPS of $, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.99 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
• UBS Downgrades Lai Yih Footwear Co Ltd (6890:TT) to Neutral